Fersamal

Quick links to important sections

Fersamal

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fersamal

What is Fersamal? (Overview and Identity)

Property Description
Active ingredient Ferrous Fumarate
Form Oral tablet, Capsule
Pharmacological class Antianemic preparation, Iron supplement
Common use Addressing Iron deficiency, Anemia
Origin Synthetic chemical compound

Fersamal is a medication containing the active ingredient Ferrous Fumarate, and it belongs to the pharmacological class of Antianemic preparations and Hematinics. This product is fundamentally a supplement used to provide the body with the essential mineral Iron, which is often depleted due to inadequate diet or physiological factors, such as during pregnancy. Ferrous Fumarate is classified by the World Health Organization Anatomical Therapeutic Chemical (ATC) system under Iron bivalent, oral preparations.

The medication is a Monoprepared product, meaning its effect is derived solely from the single active chemical entity. The compound is a synthetic chemical compound, specifically a ferrous salt that is widely recognized as an easily absorbable source of iron for replacement therapy. It is administered via the Oral route primarily as an Oral tablet or Capsule, with some markets also offering liquid forms like an Elixir or Suspension.

Composition, Purpose, and High-Level Action

The core composition of Fersamal ensures that it delivers the absorbable form of iron, the Divalent iron cation (Fe^2+). This formulation is employed to address Iron deficiency, a condition characterized by inadequate mineral stores. Ferrous Fumarate is a high-value oral iron therapy that provides a significantly high concentration of elemental iron compared to other common ferrous salts. This confirms its efficacy in restoring mineral levels necessary for healthy body function.

The general therapeutic purpose is the essential nutrient provision of iron necessary to maintain healthy red blood cells. The mechanism involves Supplementation and Replenishment, as it provides the material required for Hemoglobin synthesis. This process is vital for ensuring sufficient oxygen transport throughout the body, helping to alleviate the systemic fatigue and weakness associated with Anemia linked to iron depletion.

What side effects are possible with Fersamal?

Possible Side Effects and Safety Information

The safety profile of Ferrous Fumarate (Fersamal) is primarily defined by its effects on the digestive system and specific risks related to overdose, as documented in official regulatory labeling.

Common Adverse Reactions

Adverse reactions are classified according to frequency found in clinical experience and official documents. Gastrointestinal effects are the most commonly reported adverse events (Common, affecting up to 1 in 10 people). These are often more pronounced at the start of treatment or during initial dose adjustment and may include:

  • Nausea and vomiting
  • Constipation or diarrhea
  • Abdominal discomfort or stomach cramps
  • Darkening of stools, which is due to unabsorbed iron and is an expected, common occurrence.

System-Organ-Class and Rare Effects

The primary system affected is Gastrointestinal disorders. Rarely (Rare or Very Rare), individuals may experience Immune system disorders, such as allergic skin reactions (rash or itching), or in very rare cases, a severe systemic reaction like anaphylaxis.

Serious Safety Considerations

The most critical safety constraint highlighted in official regulatory documents involves the risk of fatal iron poisoning from overdose, especially in the pediatric population (children under six years old). Additional serious, though rare, adverse reactions documented include gastrointestinal ulceration and signs of gastrointestinal bleeding.

Safety Restrictions

Ferrous Fumarate should not be used in individuals with pre-existing conditions involving iron overload, such as haemochromatosis or haemosiderosis, as this increases the risk of severe toxicity. The medication is also restricted in certain types of non-iron-deficiency anemias.

Overdose and Emergency Response

Overdose and When to Seek Help

IMPORTANT WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Keep this product out of the reach and sight of children.

Suspected overdose must be treated as a medical emergency. If you take too many tablets, or if an accidental ingestion is suspected, contact a hospital emergency department or doctor immediately.

Overdose of Fersamal (ferrous fumarate) can be acutely toxic. Ingestion of 20 mg/kg of elemental iron is considered potentially toxic, while doses around 200–250 mg/kg are potentially fatal.

Overdose Stages & Symptoms
Early Stage (Within ~6 hours): Gastrointestinal irritation, including nausea, vomiting (which may contain blood), abdominal pain, and diarrhoea. The vomit and stools may appear grey or black.
Latent Stage (6–48 hours): Symptoms may temporarily improve or clear up. This apparent recovery does not mean the danger has passed.
Systemic Stage (Within 12–48 hours): Recurrence of severe symptoms and systemic toxicity, including hypoperfusion (low blood pressure/cool extremities), metabolic acidosis, shock (from fluid loss or cardiotoxicity), and potential organ damage (liver necrosis, kidney failure). Severe cases may involve encephalopathy (brain dysfunction), coagulation disorders, and convulsions.

Treatment is supportive and symptomatic, focusing on stabilizing the patient, correcting fluid balance, and monitoring vital signs, circulation, and cardiac rhythm. The severity of the overdose is generally classified based on clinical features and serum iron levels taken approximately four hours after ingestion.

Therapeutic Uses of Fersamal

Main Uses of Fersamal

Fersamal is a medicinal supplement primarily used to address iron deficiency within the body. Its main application is the treatment and prevention of iron-deficiency anemia, a condition characterized by a decrease in the number of red blood cells or a lack of hemoglobin due to insufficient iron levels.

Treatment of Iron-Deficiency Anemia

The primary use of Fersamal is to restore iron levels in individuals who have developed anemia. This condition often occurs when the body's demand for iron exceeds its supply, leading to symptoms such as fatigue, shortness of breath, and pale skin. By providing a concentrated source of ferrous fumarate, the medication helps the body produce the necessary hemoglobin to transport oxygen effectively through the bloodstream.

Prevention of Iron Deficiency

Fersamal is also used as a preventative measure for individuals at a higher risk of developing iron depletion. This includes:

  • Pregnancy: To support the increased blood volume and the developmental needs of the fetus.
  • Nutritional Deficiencies: For individuals whose dietary intake does not meet the daily requirements for iron.
  • Malabsorption Issues: For cases where the body has difficulty absorbing adequate iron from food sources.
  • Chronic Blood Loss: To compensate for iron lost due to specific medical conditions or physiological processes.

Benefits of Fersamal

The primary benefit of Fersamal is the replenishment of the body's iron stores. By correcting an iron deficiency, the medication supports several vital biological functions.

Improved Energy Levels

Iron is a critical component of hemoglobin. When iron levels are normalized, the blood's capacity to carry oxygen improves. This often results in a reduction of the chronic tiredness and lethargy associated with anemia, helping to restore normal energy levels for daily activities.

Support for Cellular Function

Beyond red blood cell production, iron is essential for various enzymatic reactions and cellular processes. Maintaining adequate iron levels supports the health of the immune system, cognitive function, and the maintenance of healthy hair, skin, and nails.

Regulatory References

  1. NIH MedlinePlus overview of Iron Supplements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Fersamal — Official Regulatory Information

The eligibility for Fersamal (Ferrous Fumarate) is strictly defined by official regulatory bodies, focusing on patient safety and the specific nature of the iron deficiency.


Eligibility Scope Classification
Populations Allowed Adults, The Elderly, Pregnant Women (if clinically indicated), Breast-feeding Women (if clinically indicated) [NHS/SmPC].
Populations Contraindicated Patients with iron overload conditions (e.g., Haemochromatosis or Hemosiderosis) or anaemias not caused by iron deficiency (e.g., hemolytic anemia) [FDA/DailyMed].
Absolute Contraindications Active gastrointestinal diseases such as peptic ulceration, ulcerative colitis, and regional enteritis [SmPC].

Age-Related Eligibility Rules

The tablet formulation of Fersamal is not intended for the treatment of children; liquid alternatives may be suggested. A critical regulatory warning emphasizes that accidental overdose is a leading cause of fatal poisoning in children under 6 years [DailyMed]. Use in adults and the elderly is generally permitted.

Eligibility-Related Restrictions

Use requires caution in patients with gastrointestinal conditions (like intestinal strictures or diverticulae) and is contraindicated in patients receiving repeated blood transfusions due to the risk of iron accumulation [SmPC].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fersamal (ferrous fumarate) can interact with a wide range of other oral medicines, substances, and mineral supplements. These interactions are primarily pharmacokinetic, meaning the presence of iron in the gut changes the body's absorption of the co-administered drug, often resulting in reduced efficacy of the other medicine.

Key Interacting Categories and Timing Rules

Interacting Medicine Category Specific Examples Listed in Labeling Required Timing Separation
Antibiotics Tetracyclines, Ciprofloxacin, Levofloxacin Take iron 2 hours before or 4 hours after the antibiotic.
Osteoporosis Drugs Alendronic acid, Risedronate (Bisphosphonates) Requires spacing (consult official information for precise timing).
Thyroid Hormones Levothyroxine Separate doses by at least 4 hours (oral administration).
Parkinson's Drugs Levodopa, Carbidopa, Entacapone Separate doses by 2 or more hours.
Mineral Supplements Calcium, Magnesium, Zinc Take iron 2 hours before or 2 hours after supplements/antacids.

Combinations with other substances that lower stomach acid, such as antacids or medicines for ulcers, can also decrease the absorption of Fersamal itself. Additionally, iron can decrease the absorption of medications like Methyldopa, Penicillamine, Trientine, Mycophenolate, and Cholestyramine. Regulatory classifications note interactions as Major (avoid combinations) or Moderate (usually avoid, use only under special circumstances with strict monitoring).

Mechanism of Action

How Fersamal Works: Mechanism of Action

Iron Assimilation and Systemic Transport

The drug's mechanism initiates with the provision of the essential Divalent Iron Cation ( Fe^2+). This ion is absorbed across the intestinal epithelium via the Divalent Metal Transporter 1 (DMT1) and is released into the systemic circulation by the efflux protein Ferroportin, where it binds to the plasma protein Transferrin. This process facilitates the transfer of the iron precursor systemically, but the transfer is intrinsically limited by a sufficiently acidic gastric pH and is negatively regulated by the hormone Hepcidin.

Hemoglobin Biosynthesis and Oxygen Capacity Modulation

The iron-Transferrin complex is delivered to erythroid precursor cells in the bone marrow and enters the cell via the Transferrin Receptor 1 ( TfR1). Within the cell, the released Fe^2+ acts as the necessary material for the Heme Biosynthesis pathway. The provision of this precursor material drives the production of functional Hemoglobin, which subsequently enhances the blood's intrinsic capacity for Systemic Oxygen Transport and modulates the cellular environment by increasing O2 availability. The rate of final physiological adjustment is constrained by the biological rate of erythropoiesis.

Dosage and Administration Information

How Fersamal is Used

Fersamal (Ferrous Fumarate) administration follows specific parameters to ensure appropriate dosing and absorption of elemental iron. It is a medication used via the oral route, available as tablets, capsules, or syrup for consumption by mouth.


Official Dosing and Frequency

Regimen Type Standard Adult Dose Frequency
Treatment (Anemia) 120 mg to 180 mg elemental iron total daily dose, typically one tablet (e.g., 210 mg) two to three times daily. Once, twice, or three times daily
Prophylaxis One tablet daily or twice daily. Once or twice daily

Duration of Use: Treatment is typically continued for three to six months after the patient's hemoglobin level has returned to normal. This duration is standardized to fully replenish the body's iron stores, which is a key component of the overall therapeutic protocol.


Administration Requirements

Timing and Absorption: Fersamal is best absorbed on an empty stomach (one hour before or two hours after meals). However, to minimize gastrointestinal discomfort, the medication may be taken with or immediately after food. To avoid reducing iron absorption, the dose must be separated from consuming milk/dairy products, tea, coffee, and whole grain cereals.

Dose Alteration: Tablets should generally be swallowed whole. However, certain immediate-release tablet formulations (e.g., 210 mg) may be crushed or chewed if specific swallowing difficulties exist.

Population Adjustments: For paediatric patients, weight-based dosing (typically 3 to 6 mg elemental iron/kg per day) is used, often utilizing the syrup formulation. Dosing for older adults may begin at the lower end of the adult range for optimized tolerance.

Recent Clinical Evidence

Fersamal: Recent Clinical Evidence

Ferrous fumarate, the active component of Fersamal, is a common oral iron supplement investigated extensively for its role in addressing iron deficiency anemia (IDA).

Outcomes in Anemia Treatment

Clinical trials consistently report that oral ferrous iron preparations are associated with an increase in hemoglobin (Hb) and serum ferritin levels in individuals with IDA, including pregnant women and children. One analysis pooling data from several studies suggested that a clinically meaningful increase in hemoglobin may be observed in the majority of patients by the second month of therapy.

However, the ultimate extent and speed of this change can be influenced by the patient population, the severity of the deficiency, and the dose administered. For example, some comparative studies in anemic children with inflammatory bowel disease found that intravenous (IV) iron was linked to a quicker initial improvement in physical fitness compared to oral ferrous fumarate, though the hematological outcomes were comparable at three and six months.


Tolerability and Dosing Regimens

The main challenge associated with oral iron salts is the potential for gastrointestinal side effects, such as constipation, nausea, and abdominal pain, which may affect adherence to the regimen. Research into administration frequency attempts to minimize these events while maintaining iron absorption.

  • Dosing Frequency Studies: A randomized controlled trial comparing a thrice-weekly ferrous fumarate regimen to a thrice-daily regimen in adults with IDA found that both approaches were associated with a comparable overall response in achieving target hemoglobin levels after 12 weeks. Importantly, the thrice-weekly schedule was associated with a lower incidence of gastrointestinal adverse events.
  • Comparative Trials: Studies comparing ferrous fumarate to other iron preparations have shown that while ferrous fumarate may be associated with effective increases in Hb and ferritin, it can sometimes be linked to a slightly higher frequency of adverse events compared to some newer formulations. This highlights the ongoing effort in clinical research to find optimal iron supplementation strategies that balance measurable hematological changes with patient tolerability.

Frequently Asked Questions (FAQ)

Common questions about Fersamal (FAQ)


Q: Is Fersamal a type of strong iron supplement?

A: Fersamal contains Ferrous Fumarate, which regulatory documents describe as a high-value source of iron. This is because the formulation provides a significantly higher concentration of elemental iron—the iron the body can actually absorb—compared to some other common iron salts used in supplements.


Q: Does taking Fersamal make a person feel tired or energized?

A: The primary role of Fersamal is to replenish iron stores, which are necessary for the body to produce hemoglobin and facilitate oxygen transport. By addressing an iron deficiency, the medication is intended to help alleviate the systemic fatigue and weakness often associated with anemia.


Q: How long does it usually take to feel an effect from Fersamal?

A: Based on official product information, most people may begin to notice an improvement in their well-being after taking the medicine for about one week. The time it takes to see full benefits and replenish iron stores can vary, but official information indicates a duration that usually extends beyond four weeks.


Q: Is there a best time of day to take Fersamal for it to work well?

A: Official guidance notes that iron is best absorbed on an empty stomach, such as one hour before or two hours after a meal. However, because stomach-related side effects are common, the medication may be taken with or immediately after food to help reduce gastrointestinal discomfort.


Q: What happens if a dose of Fersamal is missed?

A: Official patient information describes that if a dose is forgotten, the next dose may be taken as soon as remembered. However, do not take the missed dose if it is almost time for the next scheduled dose. It is advised not to take a double dose to compensate for a single missed dose.


Q: What kind of diet changes are usually recommended when starting Fersamal?

A: Official guidance advises separating the dose from foods and drinks that reduce iron absorption, such as tea, coffee, milk, and whole grains. While not mandatory, integrating iron-rich foods into the general diet supports the overall effort to rebuild iron stores.


Q: Is it normal to experience constipation or diarrhea when first using Fersamal?

A: Yes, regulatory documents list both constipation and diarrhea as common side effects of ferrous fumarate. These gastrointestinal disturbances are often more noticeable at the start of treatment as the body adjusts to the iron supplement.


Q: Why is it often recommended to take iron supplements with Vitamin C?

A: Official labeling and studies have noted that Ascorbic Acid (Vitamin C) is a substance that may increase the absorption of oral iron. This is a common strategy used to potentially enhance the body's uptake of the mineral from the supplement.


Q: Does the Fersamal tablet need to be swallowed whole, or can it be crushed?

A: In general, regulatory documents state that the tablets should be swallowed whole with water. The regulatory guidance is that the tablets are generally not to be sucked or chewed. However, certain immediate-release tablet formulations may be crushed or chewed if specific difficulties with swallowing exist.


Q: Are there any common over-the-counter pain relievers that interact with Fersamal?

A: Regulatory documents list several drug categories that interact with iron, but they do not list every common over-the-counter pain reliever. Official guidance advises consulting a healthcare professional or pharmacist to determine the appropriate timing separation for any medicine taken alongside Fersamal.


Q: Is Fersamal available to buy without a prescription?

A: Ferrous Fumarate is a regulated medication that can be obtained on a prescription. Depending on the strength and the regional regulations, it may also be available for purchase from pharmacies without a prescription.


Q: Are there any long-term effects of taking Fersamal that people should know about?

A: Regulatory documents indicate that treatment duration typically does not need to exceed three months after the correction of anemia, which is done to help prevent iron accumulation. Also, the syrup formulation may carry an increased risk of dental caries (cavities) with prolonged use.


Q: Do any official documents describe Fersamal's impact on mood or sleep?

A: While iron deficiency itself can affect energy and mood, some official documentation for iron preparations combined with folic acid has noted potential nervous system effects. These can include concentration problems, anxiety, and sleep disturbances.


Q: Is Fersamal known to cause headaches or dizziness?

A: Headaches are not commonly listed as a primary side effect of ferrous fumarate in regulatory documents. However, official information describes that sudden, severe dizziness or confusion are conditions for which medical attention is recommended.


Q: Is Fersamal ever used for reasons other than iron deficiency?

A: The approved indications—or reasons for use—listed in official regulatory documents for Ferrous Fumarate are the prevention and treatment of iron deficiency anemia.


Q: Is Fersamal suitable for people with diabetes?

A: The Fersamal syrup formulation contains sugar, which is an important consideration for individuals managing blood sugar levels. This requires caution in patients with diabetes mellitus, and official product information should be reviewed for details regarding the specific sugar content.


Q: Are there specific food types that should be avoided completely with Fersamal?

A: Official guidance focuses on separating the dose from certain absorption-blocking foods like milk, tea, and whole grains, rather than avoiding those foods completely in your diet. This separation is intended to prevent a reduction in the effect of the iron tablets.


Q: Does taking Fersamal require any special monitoring by a healthcare professional?

A: Treating iron deficiency anemia typically requires addressing the underlying cause of the deficiency. Official guidance notes that medical advice is generally recommended if symptoms of iron deficiency do not show improvement after approximately four weeks of use.

How should Fersamal be stored and disposed of?

How to Store and Dispose of Fersamal?

The storage and disposal of Fersamal (Ferrous Fumarate) must strictly follow official regulatory guidelines to maintain product stability and ensure public safety.

Storage Requirements

Condition Syrup (140mg/5ml) Tablets (210mg)
Temperature Store below 25 C Store at Controlled Room Temperature (20 C to 25 C)
Protection Keep in the outer carton to protect from light Store away from excess heat and moisture
Container Keep the container tightly closed

Stability and Child Safety

Fersamal syrup, once opened, must be used within one month. The container must be kept tightly closed. Due to the risk of fatal iron poisoning, this medicine must be kept strictly out of the sight and reach of children.

Disposal Instructions

Unused or expired Fersamal must not be thrown away via wastewater or household waste. Disposal must be carried out in accordance with local requirements, which typically involves returning the product to a pharmacist or medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fersamal found in:

A-Z Index: